Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,376 | -18,148 | -9,955 | -41,658 | -31,846 |
| Depreciation Amortization | 1,943 | 773 | 383 | 1,555 | 1,171 |
| Income taxes - deferred | 23 | 15 | 8 | 28 | 20 |
| Accounts receivable | N/A | -38 | N/A | 1,060 | 1,060 |
| Accounts payable and accrued liabilities | -2,094 | -2,131 | 2,683 | -487 | -1,922 |
| Other Working Capital | -9,325 | -5,686 | -1,523 | 4,770 | 133 |
| Other Operating Activity | 4,915 | 4,137 | -1,648 | 7,981 | 8,573 |
| Operating Cash Flow | $-27,914 | $-21,078 | $-10,052 | $-26,751 | $-22,811 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 25 | 25 | 25 | -95 | -95 |
| Other Investing Activity | -158 | -158 | -158 | 0 | 0 |
| Investing Cash Flow | $-133 | $-133 | $-133 | $-95 | $-95 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -21,244 | -6,000 | N/A | N/A | -14,806 |
| Common Stock Issued | 46,285 | 20,346 | 13,748 | -14,699 | 25 |
| Financing Cash Flow | $25,041 | $14,346 | $13,748 | $-14,699 | $-14,781 |
| Beginning Cash Position | 13,318 | 13,318 | 13,318 | 54,863 | 54,864 |
| End Cash Position | 10,312 | 6,453 | 16,881 | 13,318 | 17,177 |
| Net Cash Flow | $-3,006 | $-6,865 | $3,563 | $-41,545 | $-37,687 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,914 | -21,078 | -10,052 | -26,751 | -22,811 |
| Capital Expenditure | N/A | N/A | N/A | -95 | -95 |
| Free Cash Flow | -27,914 | -21,078 | -10,052 | -26,846 | -22,906 |